APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Solutions (Colloids)

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Solutions (Colloids) Market Outlook and Growth Opportunities 2026

Report ID 174004350421 December 2025190 pages

Choose your research edition.

Industry ResearchIntravenous Solutions (Colloids) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Solutions (Colloids) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Intravenous Solutions (Colloids) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Solutions (Colloids) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Solutions (Colloids) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.

This report provides an overview of the global Intravenous Solutions (Colloids) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Intravenous Solutions (Colloids) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Solutions (Colloids) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Solutions (Colloids) market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Solutions (Colloids) Segment by Company

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Terumo Medical Corporation

Grifols S.A.

Intravenous Solutions (Colloids) Segment by Type

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous Solutions (Colloids) Segment by Application

Hospital and Clinics

Ambulatory

Home Care

Intravenous Solutions (Colloids) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Solutions (Colloids) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Solutions (Colloids) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Solutions (Colloids) significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Solutions (Colloids) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions (Colloids) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions (Colloids) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions (Colloids).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Solutions (Colloids) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Solutions (Colloids) industry.

Chapter 3: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Solutions (Colloids) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Solutions (Colloids) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Solutions (Colloids) Industry Trends Table 2. Intravenous Solutions (Colloids) Industry Drivers Table 3. Intravenous Solutions (Colloids) Industry Opportunities and Challenges Table 4. Intravenous Solutions (Colloids) Industry Restraints Table 5. Global Intravenous Solutions (Colloids) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Solutions (Colloids) Revenue Share by Company (2021-2026) Table 7. Global Intravenous Solutions (Colloids) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Intravenous Solutions (Colloids) Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Solutions (Colloids) Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Intravenous Solutions (Colloids) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Solutions (Colloids) Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Solutions (Colloids) Company, Product Type & Application Table 13. Global Intravenous Solutions (Colloids) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Peripheral Parenteral Nutrition Table 18. Significant Companies of Total Parenteral Nutrition Table 19. Global Intravenous Solutions (Colloids) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Intravenous Solutions (Colloids) Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Intravenous Solutions (Colloids) Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Intravenous Solutions (Colloids) Sales Volume Share by Type (2021-2026) Table 23. Global Intravenous Solutions (Colloids) Sales Volume Share by Type (2027-2032) Table 24. Global Intravenous Solutions (Colloids) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Intravenous Solutions (Colloids) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Intravenous Solutions (Colloids) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Intravenous Solutions (Colloids) Sales Value Share by Type (2021-2026) Table 28. Global Intravenous Solutions (Colloids) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinics Table 30. Significant Companies of Ambulatory Table 31. Significant Companies of Home Care Table 32. Global Intravenous Solutions (Colloids) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Intravenous Solutions (Colloids) Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Intravenous Solutions (Colloids) Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Intravenous Solutions (Colloids) Sales Volume Share by Application (2021-2026) Table 36. Global Intravenous Solutions (Colloids) Sales Volume Share by Application (2027-2032) Table 37. Global Intravenous Solutions (Colloids) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Intravenous Solutions (Colloids) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Intravenous Solutions (Colloids) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Intravenous Solutions (Colloids) Sales Value Share by Application (2021-2026) Table 41. Global Intravenous Solutions (Colloids) Sales Value Share by Application (2027-2032) Table 42. Global Intravenous Solutions (Colloids) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Intravenous Solutions (Colloids) Sales by Region (2021-2026) & (K Units) Table 44. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2021-2026) Table 45. Global Intravenous Solutions (Colloids) Sales by Region (2027-2032) & (K Units) Table 46. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2027-2032) Table 47. Global Intravenous Solutions (Colloids) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Intravenous Solutions (Colloids) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Intravenous Solutions (Colloids) Sales Value Share by Region (2021-2026) Table 50. Global Intravenous Solutions (Colloids) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Intravenous Solutions (Colloids) Sales Value Share by Region (2027-2032) Table 52. Global Intravenous Solutions (Colloids) Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Intravenous Solutions (Colloids) Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Intravenous Solutions (Colloids) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units) Table 57. Global Intravenous Solutions (Colloids) Sales Market Share by Country (2021-2026) Table 58. Global Intravenous Solutions (Colloids) Sales by Country (2027-2032) & (K Units) Table 59. Global Intravenous Solutions (Colloids) Sales Market Share by Country (2027-2032) Table 60. Global Intravenous Solutions (Colloids) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Intravenous Solutions (Colloids) Sales Value Market Share by Country (2021-2026) Table 62. Global Intravenous Solutions (Colloids) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Intravenous Solutions (Colloids) Sales Value Market Share by Country (2027-2032) Table 64. ICU Medical Inc. Company Information Table 65. ICU Medical Inc. Business Overview Table 66. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio Table 68. ICU Medical Inc. Recent Development Table 69. B. Braun Melsungen AG Company Information Table 70. B. Braun Melsungen AG Business Overview Table 71. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio Table 73. B. Braun Melsungen AG Recent Development Table 74. Fresenius Kabi AG Company Information Table 75. Fresenius Kabi AG Business Overview Table 76. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio Table 78. Fresenius Kabi AG Recent Development Table 79. Baxter Company Information Table 80. Baxter Business Overview Table 81. Baxter Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Baxter Intravenous Solutions (Colloids) Product Portfolio Table 83. Baxter Recent Development Table 84. Amanta Healthcare Company Information Table 85. Amanta Healthcare Business Overview Table 86. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio Table 88. Amanta Healthcare Recent Development Table 89. Terumo Medical Corporation Company Information Table 90. Terumo Medical Corporation Business Overview Table 91. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio Table 93. Terumo Medical Corporation Recent Development Table 94. Grifols S.A. Company Information Table 95. Grifols S.A. Business Overview Table 96. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio Table 98. Grifols S.A. Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Intravenous Solutions (Colloids) Distributors List Table 102. Intravenous Solutions (Colloids) Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Intravenous Solutions (Colloids) Product Image Figure 2. Global Intravenous Solutions (Colloids) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Solutions (Colloids) Sales (2021-2032) & (K Units) Figure 5. Global Intravenous Solutions (Colloids) Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Intravenous Solutions (Colloids) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Peripheral Parenteral Nutrition Image Figure 10. Total Parenteral Nutrition Image Figure 11. Global Intravenous Solutions (Colloids) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Intravenous Solutions (Colloids) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Intravenous Solutions (Colloids) Sales Volume Share by Type (2021-2032) Figure 14. Global Intravenous Solutions (Colloids) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Intravenous Solutions (Colloids) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Solutions (Colloids) Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinics Image Figure 18. Ambulatory Image Figure 19. Home Care Image Figure 20. Global Intravenous Solutions (Colloids) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Intravenous Solutions (Colloids) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Intravenous Solutions (Colloids) Sales Volume Share by Application (2021-2032) Figure 23. Global Intravenous Solutions (Colloids) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Intravenous Solutions (Colloids) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Intravenous Solutions (Colloids) Sales Value Share by Application (2021-2032) Figure 26. Global Intravenous Solutions (Colloids) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Intravenous Solutions (Colloids) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Intravenous Solutions (Colloids) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Intravenous Solutions (Colloids) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Intravenous Solutions (Colloids) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Intravenous Solutions (Colloids) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Intravenous Solutions (Colloids) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Intravenous Solutions (Colloids) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Intravenous Solutions (Colloids) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Intravenous Solutions (Colloids) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Intravenous Solutions (Colloids) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Intravenous Solutions (Colloids) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition
Applications
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Companies covered
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter
  • Amanta Healthcare
  • Terumo Medical Corporation
  • Grifols S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Solutions (Colloids) Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Solutions (Colloids) Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Solutions (Colloids) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Solutions (Colloids) Market Dynamics
  1. 2.1 Intravenous Solutions (Colloids) Industry Trends
  2. 2.2 Intravenous Solutions (Colloids) Industry Drivers
  3. 2.3 Intravenous Solutions (Colloids) Industry Opportunities and Challenges
  4. 2.4 Intravenous Solutions (Colloids) Industry Restraints
3 Intravenous Solutions (Colloids) Market by Company
  1. 3.1 Global Intravenous Solutions (Colloids) Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Solutions (Colloids) Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Solutions (Colloids) Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Solutions (Colloids) Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Solutions (Colloids) Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Solutions (Colloids) Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Solutions (Colloids) Company Product Type and Application
  8. 3.8 Global Intravenous Solutions (Colloids) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Solutions (Colloids) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Solutions (Colloids) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Solutions (Colloids) Market by Type
  1. 4.1 Intravenous Solutions (Colloids) Type Introduction
  2. 4.1.1 Peripheral Parenteral Nutrition
  3. 4.1.2 Total Parenteral Nutrition
  4. 4.2 Global Intravenous Solutions (Colloids) Sales Volume by Type
  5. 4.2.1 Global Intravenous Solutions (Colloids) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous Solutions (Colloids) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Intravenous Solutions (Colloids) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Intravenous Solutions (Colloids) Sales Value by Type
  9. 4.3.1 Global Intravenous Solutions (Colloids) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous Solutions (Colloids) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Intravenous Solutions (Colloids) Sales Value Share by Type (2021-2032)
5 Intravenous Solutions (Colloids) Market by Application
  1. 5.1 Intravenous Solutions (Colloids) Application Introduction
  2. 5.1.1 Hospital and Clinics
  3. 5.1.2 Ambulatory
  4. 5.1.3 Home Care
  5. 5.2 Global Intravenous Solutions (Colloids) Sales Volume by Application
  6. 5.2.1 Global Intravenous Solutions (Colloids) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Solutions (Colloids) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Solutions (Colloids) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Solutions (Colloids) Sales Value by Application
  10. 5.3.1 Global Intravenous Solutions (Colloids) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Solutions (Colloids) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Solutions (Colloids) Sales Value Share by Application (2021-2032)
6 Intravenous Solutions (Colloids) Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Solutions (Colloids) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Solutions (Colloids) Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Solutions (Colloids) Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Solutions (Colloids) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Solutions (Colloids) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Solutions (Colloids) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Solutions (Colloids) Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Solutions (Colloids) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Solutions (Colloids) Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Solutions (Colloids) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Solutions (Colloids) Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Solutions (Colloids) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Solutions (Colloids) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Solutions (Colloids) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Solutions (Colloids) Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Solutions (Colloids) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Solutions (Colloids) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Solutions (Colloids) Sales Value Share by Country, 2025 VS 2032
7 Intravenous Solutions (Colloids) Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Solutions (Colloids) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Solutions (Colloids) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Solutions (Colloids) Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Solutions (Colloids) Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Solutions (Colloids) Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Solutions (Colloids) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Solutions (Colloids) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Solutions (Colloids) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Solutions (Colloids) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Solutions (Colloids) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Solutions (Colloids) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ICU Medical Inc.
  2. 8.1.1 ICU Medical Inc. Company Information
  3. 8.1.2 ICU Medical Inc. Business Overview
  4. 8.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
  6. 8.1.5 ICU Medical Inc. Recent Developments
  7. 8.2 B. Braun Melsungen AG
  8. 8.2.1 B. Braun Melsungen AG Company Information
  9. 8.2.2 B. Braun Melsungen AG Business Overview
  10. 8.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
  12. 8.2.5 B. Braun Melsungen AG Recent Developments
  13. 8.3 Fresenius Kabi AG
  14. 8.3.1 Fresenius Kabi AG Company Information
  15. 8.3.2 Fresenius Kabi AG Business Overview
  16. 8.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
  18. 8.3.5 Fresenius Kabi AG Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 Amanta Healthcare
  26. 8.5.1 Amanta Healthcare Company Information
  27. 8.5.2 Amanta Healthcare Business Overview
  28. 8.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
  30. 8.5.5 Amanta Healthcare Recent Developments
  31. 8.6 Terumo Medical Corporation
  32. 8.6.1 Terumo Medical Corporation Company Information
  33. 8.6.2 Terumo Medical Corporation Business Overview
  34. 8.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
  36. 8.6.5 Terumo Medical Corporation Recent Developments
  37. 8.7 Grifols S.A.
  38. 8.7.1 Grifols S.A. Company Information
  39. 8.7.2 Grifols S.A. Business Overview
  40. 8.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
  42. 8.7.5 Grifols S.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Solutions (Colloids) Value Chain Analysis
  2. 9.1.1 Intravenous Solutions (Colloids) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Solutions (Colloids) Sales Mode & Process
  6. 9.2 Intravenous Solutions (Colloids) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Solutions (Colloids) Distributors
  9. 9.2.3 Intravenous Solutions (Colloids) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst